Documente Academic
Documente Profesional
Documente Cultură
presentation
DISSERTATION PROPOSAL
ON
KQ5
KQ5
Interventions
Interventions for
for
acute
acute blood
blood loss
loss
Interventions
Interventions anemia
anemia
Compression
Compression
techniques
techniques
Management
Management of of Medications
Medications
Postpartum
Postpartum Hemorrhage
Hemorrhage Procedures
Procedures KQ4 Final
Intermediated
Intermediated KQ4 Final health
health
(PPH)
(PPH) Women
Women withwith PPH
PPH Surgeries
Surgeries outcomes
outcomes
outcomes outcomes
immediately
immediately post-birth to
post-birth to Mortality
Blood
Blood loss
loss Mortality
12
12 weeks
weeks postpartum
postpartum Uterine
KQ1
KQ1 KQ2
KQ2 Transfusion
Transfusion Uterine
following
following pregnancy
pregnancy of of ≥≥ preservation
ICU
ICU admission
admission preservation
24 weeks gestation
24 weeks gestation future
KQ3
KQ3 Anemia
Anemia future fertility
fertility
Compression
Compression techniques
techniques Breastfeeding
Length
Length of
of stay
stay Breastfeeding
Medications
Medications Psychological
Psychological
Procedures
Procedures Harms Impact
Impact
Surgeries
Surgeries Resolution
Resolution of of
Blood
Blood and
and fluid
fluid products
products anemia
anemia
Anti-shock
Anti-shock garment
garment Harms
Harms of of
treatment
treatment
Review of Literature
We selected potential risk factors for consideration in our analyses.
Pre-pregnancy factors included marital status, ethnicity, uterine
anomalies (septated uterus, uni- or bicornuate uterus, uterus
didelphys), previous uterine surgery (myomectomy and septal
removals), previous cesarean section, previous severe PPH (≥1500
mL), and uterine fibromas. Current pregnancy conditions included
maternal age, ethnicity (country of origin), pre-pregnancy body
mass index (BMI), anemia in start of pregnancy (hemoglobin ≤9
g/dL), assisted reproductive technology (in vitro fertilization [IVF]
or intra-cytoplasmic sperm injection [ICSI]), multiple pregnancy,
gestational diabetes (insulin treated or diet regulated), use of
anticoagulant medications such as low molecular weight heparin
(LMWH) in pregnancy, polyhydramnios, severe preeclampsia or
HELLP-syndrome, and premature rupture of membranes (PROM).
Methods and Materials
Study Design